Fish oil and wheat germ oil in hemodialysis patients

clnincal study evaluating the potential various effects of fish oil and wheat germ oil combination in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201703002082231

Enrollment

Registered

2017-03-08

Start date

2016-09-29

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

we studied different cardiovascular risk factor in hemodialysis patients Kidney Disease

Interventions

Fish oil plus wheat germ oil

Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: both sexes age >20 years ongoing regular HD treatment for at least 6 months prior to the study

Exclusion criteria

Exclusion criteria: recently dialysed patients (less than 6 months) pregnant women active infections active liver disease malignancy recurrent bleeding recent surgery a history of inflammatory disease previous noncompliance with HD or medication regimens concurrent use of medications that could interfere with assessed parameters such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressives or immunomodulators

Design outcomes

Secondary

Measure	Time frame
significant increase in serum calcium levels;no effect on anemia	—

Countries

Egypt

Contacts

Public ContactGamal A. Elazb

gelazab@yahoo.com201022772509

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026